Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Disorders of the Male Reproductive System

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...

Hypertension IV: Drug Therapy and Lifestyle Modifications

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...

COPD: Management Using Bronchodilators and Corticosteroids

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...

Coronary Artery Disease IV: Preventive Measures

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Urinary Tract Infectious Complications After Retrograde Intrarenal Surgery: The RIRS-STAMP Risk Score from a Two-Center Cohort.

Pathogens (Basel, Switzerland)·2026

Same author

Preoperative renal pelvis urine density predicts postoperative infection after pediatric retrograde intrarenal surgery: A multicenter retrospective cohort study.

Journal of pediatric urology·2026

Same author

Role of Metabolic Syndrome in Male Fertility: Is It a Risk Factor?

Archivos espanoles de urologia·2025

Same author

Proposal for an Expanded "R" Classification: Impact of Positive Surgical Margin Length on Biochemical Recurrence After Robotic Radical Prostatectomy.

Journal of clinical medicine·2025

Same author

Psychological and Pain Factors in Microsurgical Testicular Sperm Extraction (Micro-TESE) for Non-Obstructive Azoospermia: A Comparative Study of Successful and Unsuccessful Cases.

Urology journal·2024

Same author

A Retrospective Analysis of 83 Patients with Testicular Mass Who Underwent Testis-Sparing Surgery: The Eurasian Uro-oncology Association Multicenter Study.

Urologia internationalis·2023

Search research articles

Related Experiment Video

Updated: Jul 9, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

Do lifestyle changes work for improving erectile dysfunction?

Kaya Horasanli¹, Ugur Boylu, Muammer Kendirci

¹Sisli Etfal Egitim ve Arastirma Hastanesi, 2. Uroloji Klinigi, Sisli-34377, Istanbul, Turkey.

Asian Journal of Andrology

|December 19, 2007

Summary

This summary is machine-generated.

Lifestyle changes like quitting smoking, losing weight, and exercising can significantly improve erectile dysfunction (ED) and reduce cardiovascular disease risk. Addressing these factors is crucial for men's health.

Related Experiment Videos

Last Updated: Jul 9, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

Area of Science:

Urology
Cardiovascular Health
Men's Health

Background:

Erectile dysfunction (ED) is primarily organic, with vascular issues being common.
Established risk factors include aging, diabetes, hypertension, and dyslipidemia.
The role of lifestyle factors in ED has been historically underemphasized by urologists.

Purpose of the Study:

To review the impact of lifestyle factors on erectile function.
To highlight the benefits of lifestyle modification for ED management.
To connect ED improvement with cardiovascular disease risk reduction.

Main Methods:

Review of current scientific literature and clinical studies.
Analysis of data linking lifestyle factors to erectile function.
Synthesis of evidence from animal and human research.

Main Results:

Smoking, obesity, alcohol consumption, and physical inactivity are linked to ED.
Modifying these lifestyle factors shows promise in improving erectile function.
Lifestyle changes can concurrently lower cardiovascular disease risks.

Conclusions:

Lifestyle modifications are essential for managing erectile dysfunction.
Integrating lifestyle advice into clinical practice can enhance patient outcomes.
Addressing lifestyle factors offers a dual benefit for sexual health and overall cardiovascular well-being.